Keyphrases
Intensive Care Unit
100%
Indonesia
65%
Enterobacteriaceae
61%
Klebsiella Pneumoniae (K. pneumoniae)
53%
Streptococcus Pneumoniae
52%
Risk Factors
47%
Jakarta
33%
Acinetobacter Baumannii (A. baumannii)
28%
Pseudomonas Aeruginosa (P. aeruginosa)
28%
Community-acquired Pneumonia
28%
Gram-negative Bacteria
27%
CDR2
23%
Fluconazole Resistance
23%
ERG11 Gene
23%
Melioidosis
23%
Gel Hand Sanitizer
23%
Epithelial Cells
23%
CNS Infection
23%
Risk Outcomes
23%
Modul
23%
Overexpression
23%
Leukocytes
23%
β-lactamase
23%
Candida Albicans (C. albicans)
23%
Extended-spectrum beta-lactamase-producing Klebsiella Pneumoniae
23%
Salam
23%
Carbapenemase Genes
23%
Carbapenemase
23%
Cell Count
23%
Gene Family
23%
Indonesian Hospital
23%
C.albicans
23%
Human Immunodeficiency Virus Patients
23%
Platinum Coating
23%
Etiology
23%
Polyetheretherketone Implant
23%
Brain Infection
23%
Improved Biocompatibility
23%
Pathogen Detection
23%
Phenotypic Characterization
23%
Genetic Mechanism
23%
Bark Extract
23%
Bacteriophage Lysin
23%
Clonality Analysis
23%
Sandblasting
23%
Implant Surface
23%
Multidrug-resistant
23%
Pneumonia in children
23%
Enhanced Stability
23%
Antimicrobial Activity
23%
Pharmacology, Toxicology and Pharmaceutical Science
Enterobacteriaceae
69%
Extended Spectrum Beta Lactamase
65%
Carbapenemase
47%
Infection
46%
Prevalence
40%
Gram Negative Bacterium
31%
Pseudomonas aeruginosa
31%
Staphylococcus Aureus
25%
Base
23%
Extended Spectrum Beta Lactamase Producing Klebsiella Pneumoniae
23%
Bacteriophage
23%
Apigenin
23%
Triethanolamine
23%
Staphylococcal Pneumonia
23%
Antimicrobial Agent
23%
Beta Lactamase
23%
Minimum Inhibitory Concentration
23%
Acinetobacter Baumannii
23%
Agar
23%
Celery
23%
Hand Sanitizer
23%
Carbomer
23%
Infectious Agent
19%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
17%
Non-Fermenter
15%
Diseases
15%
Antiinfective Agent
13%
Amikacin
11%
Klebsiella pneumoniae
11%
Carbapenem Derivative
11%
Antimicrobial Resistance
11%
Mortality Rate
11%
Penicillinase
11%
Cross-Sectional Study
7%
Healthcare Associated Infection
7%
Escherichia coli
5%
Flavonoid
5%
Amoxicillin
5%
Carbapenem
5%
Cefoxitin
5%
Combination Therapy
5%
Inflammation
5%
Anti-Inflammatory Drug
5%
Methicillin-Resistant Staphylococcus Aureus
5%
Microorganism
5%
Enterobacter Cloacae
5%
Enterobacter Aerogenes
5%
Antibiotics
5%
Gram Positive Bacterium
5%
Carbapenem Resistant Enterobacteriaceae
5%
Medicine and Dentistry
Intensive Care Unit
80%
Extended Spectrum Beta Lactamase
55%
Enterobacteriaceae
47%
Gram-Negative Bacteria
28%
Prevalence
26%
Beta-Lactamase
26%
Multigene Family
23%
Central Nervous System Infection
23%
Melioidosis
23%
Cross Sectional Study
23%
Extended Spectrum Beta Lactamase Producing Klebsiella Pneumoniae
23%
Brain Infection
23%
Cohort Analysis
23%
Infection
23%
Multidrug-Resistant Gram-Negative Bacteria
23%
Carbapenemase
16%
Diseases
15%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
14%
Tuberculous Meningitis
11%
Human Immunodeficiency Virus
11%
Klebsiella pneumoniae
10%
Bacterial Colonization
10%
Amikacin
9%
Escherichia coli
7%
Microbiological Examination
7%
Neurosyphilis
5%
Herpes Simplex Virus
5%
HIV Test
5%
Patient Referral
5%
Epileptic Seizure
5%
Cryptococcal Meningitis
5%
Loss of Consciousness
5%
Cryptococcosis
5%
Mucormycosis
5%
Glasgow Outcome Scale
5%
Headache
5%
Cell Count
5%
Varicella Zoster Virus
5%
Cerebrospinal Fluid
5%
Cerebral Toxoplasmosis
5%
Hospital Mortality
5%
Cytomegalovirus
5%
Toxoplasmosis
5%
Human Immunodeficiency Virus Infection
5%
Mixed Infection
5%
Encephalitis
5%
